You are on Home >> ModiQuest Research latest Innovation for treating Rheumatoid Arthritis

ModiQuest Research latest Innovation for treating Rheumatoid Arthritis

This newly generated antibody generation  consists of extensive antibody generation technology platform, which include phage display and high throughput mouse hybridoma generation, ModiQuest identified specific anti-citrullin antibodies that accounts high efficacy levels in preclinical RA models.

ModiQuest has been successful in providing many  different autoimmune disease projects as well as rheumatoid arthritis, including multiple sclerosis , and lupus erythematosus. Simply by using a mix of an original technology service platform plus a growing variety of immunological reagents for autoimmune disease research, ModiQuest supplies the antibody expertise, along with customized antigens, monoclonal antibodies and enzymes specifically made for early diagnosis along with therapeutic research.

About rheumatoid arthritis

Rheumatoid arthritis is a chronic disorder or systematic inflammatory disorder that affects the tissues and the organs in the affected person’s body, the major part of the body that gets affected by this health complication are the synovial joints. There are several severe health effects of this complication on health as the person suffering from this health complication experiences severe pain in the joints. Rheumatoid arthritis cause s destruction of the articular cartilage and also causes some destruction in the joints. Rheumatoid arthritis also produces inflammation in the lungs and many more delicate organs in the body. There are several reasons that may lead to this fatal health complication but the exact reasons that lead to this complication are still unknown. Rheumatoid arthritis is categorized under systematic autoimmune disease; rheumatoid arthritis is based on the term rheumatic fever which usually leads to severe joint pains.

Almost 1%of the population in the world is suffering from this health complication called rheumatoid arthritis. Mostly this complication affects men and women in their middle age that varies from 40-50 years.

About ModiQuest

ModiQuest research is well known for the immense knowledge and the experience in antibody technologies.  ModiQuest is excellent in the development and production of anti-body therapies in at a cost effective price. ModiQuest helps to maximize the potential of the research.